Search results

20 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC surgeons co-author study on breast cancer treatment decision making
Chapel Hill, NC - How much medical information does a woman understand and retain about her breast cancer diagnosis? UNC scientists participated in a four-institution study involving 440 women with early-stage breast cancer and found that breast cancer survivors had limited knowledge about their surgical options, including an understanding of something as important as the risk of recurrence.
Located in News / 2012 News
UNC Lineberger geriatric oncology program leaders co-author Journal of Clinical Oncology editorial about older women and breast cancer
UNC Lineberger Geriatric Oncology program leaders Hy Muss, MD, and Jan Busby-Whitehead, MD, co-authored an editorial in the December 10, 2011 issue of the Journal of Clinical Oncology. Muss is professor of medicine. Busby-Whitehead is professor of medicine, and director of the UNC School of Medicine’s Center for Aging and Health and Division of Geriatric Medicine.
Located in News / 2012 News
Editorial urges rapid clinical trials for targeted breast cancer therapies
Chapel Hill, NC – In an editorial published today in the Journal of Clinical Oncology, UNC associate professor E. Claire Dees, MD, reviews current evidence on the safety and efficacy of combination therapies currently used for metastatic breast cancer and urges clinical researchers to move forward with new studies that leverage advances in the identification of tumor biomarkers.
Located in News / 2011 News
UNC scientist receives grant to identify biomarkers for breast cancer recurrence risk
Chapel Hill - A UNC scientist was awarded one of seven grants presented by the Avon Walk for Breast Cancer at their seventh annual event in Charlotte, NC.
Located in News / 2011 News
Study quantifies false positives for yearly mammograms
Breast Cancer Surveillance Consortium also compares digital and film mammography
Located in News / 2011 News
Triple-Negative Breast Cancer: Still A Hard Fight For African-American Women
Keith Amos, MD, quoted in The Huffington Post
Located in News / 2011 News
Causes of African-American breast cancer incidence study receives $19.3M: UNC partners to form largest US database
Chapel Hill - UNC scientist Robert Millikan will partner with Christine Ambrosone, of Roswell Park Cancer Institute, and Julie R. Palmer, of Boston University, in the most ambitious study to date of breast cancer among younger African-American women.
Located in News / 2011 News
UNC study looks at dose levels of the breast cancer drug, tamoxifen
Using a patient’s genetic information can be successfully used to manage the drug concentrations of tamoxifen, a drug used to treat and prevent breast cancer.
Located in News / 2011 News
Common transplant drug inhibits breast cancer growth, UNC laboratory study shows
Chapel Hill - Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th Public Library of Science.
Located in News / 2011 News
UNC study: New genomic test may guide breast cancer treatment choices
UNC study: New genomic test may guide breast cancer treatment choices
Located in News / 2011 News